Review explores how microRNAs (miRNAs) interact in cancer development, their potential in diagnosis, and innovative ...

The company employs machine learning to uncover disease mechanisms at the mRNA level and to identify therapeutic candidates.

In an era where viral outbreaks can escalate into global pandemics with alarming speed, the ability to quickly develop new vaccines has become crucial.

The most recent trading session ended with Moderna (MRNA) standing at $57.73, reflecting a -0.96% shift from the previouse trading day's closing. This change lagged the S&P 500's daily gain of 0.77%.

In that respect it follows a similar model to Merck's takeover of AmpTec, another CDMO that uses a PCR platform to make mRNA drugs, for an undisclosed sum last year. Outsourcing services are on of ...

At first, the researchers used the SiLNP variants to deliver mRNA encoding for firefly luciferase, the gene that causes fireflies to glow, to cancerous liver cells in an animal model, as a proxy ...

Moderna (MRNA) closed at $58.39 in the latest trading ... changes into account and delivers a clear, actionable rating model. The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 ...

We recently compiled a list of the Jim Cramer’s List of Stocks that Finished Dead Last. In this article, we are going to take ...

In the late 1980s, Ambros and Ruvkun were postdoctoral researchers in the laboratory of Robert Horvitz, who received the ...